Agatha Zawadzka

Agatha Zawadzka has extensive experience in the field of scientific research and development. Agatha currently holds the role of Senior Scientist II at Scholar Rock, starting in March 2023. Prior to this, they worked at PureTech Health as a Senior Scientist from May 2020 to February 2023, where they were responsible for designing and managing a multiplex IHC workflow and providing IHC solutions for multiple technology platforms.

Before their role at PureTech Health, Agatha worked as a Scientist at Surface Oncology Inc. from October 2019 to May 2020. Agatha also gained significant experience at Takeda Oncology, where they served as an Associate Scientist from June 2014 to October 2019.

Agatha has a strong background in bioassay development, as demonstrated by their role as a Sr. Bioassay Development Associate IV at Organogenesis Inc. from October 2009 to February 2014. Agatha was responsible for identifying suitable biomarkers in wound healing animal models and designing/implementing state-of-the-art IHC for comparison purposes.

Their earlier experience includes positions as a Research Scientist at Intercytex Ltd. from April 2008 to September 2009, at Mytogen/Advanced Cell Technology from December 2005 to April 2008, and at GenVec from April 2004 to November 2005. Agatha began their career as an Associate Research Scientist at Diacrin Inc. in March 1991 and worked there until April 2004.

Agatha Zawadzka's work experience highlights their expertise in scientific research and development, particularly in areas such as IHC, bioassay development, and biomarker identification.

Agatha Zawadzka obtained a Master of Science - MS degree from the University of Life Sciences in Warsaw, Poland. Alongside, they pursued studies in Immunology at Harvard Extension School. The specific years of education are not provided.